S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Mack-Cali Realty Corporation Announces Fourth Quarter Results (2015/2/19)|
|Mack-Cali Realty Corporation Announces Fourth Quarter 2014 Earnings Release Date (2015/1/30)|
|Merrimack Pharmaceuticals Names Birgit M. Schoeberl, Ph.D. as Head of Discovery Division and Announces the Addition of Ulrik B. Nielsen, Ph.D. to Its Board of Directors (2015/1/22)|
|Merrimack Pharmaceuticals Announces Initiation of a Phase 2 Biomarker-Selected Clinical Trial of MM-121 in Patients with Heregulin Positive Non-Small Cell Lung Cancer (2015/2/19)|
|Merrimack Pharmaceuticals Presents Research on Innovative Pipeline for Patients With Breast Cancer at the 2014 San Antonio Breast Cancer Symposium (2014/12/12)|
|Merrimack Pharmaceuticals to Present at Oppenheimer 25th Annual Healthcare Conference, Hold Analyst Day and Present Research on Multiple Molecules in December 2014 (2014/12/1)|
|Merrimack Pharmaceuticals Announces the Addition of Russell T. Ray to Its Board of Directors (2014/12/17)|
|Merrimack Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference (2015/1/7)|
|Merrimack Pharmaceuticals Announces Timing of Fourth Quarter 2014 Investor Conference Call (2015/2/12)|
|Merrimack Pharmaceuticals Announces Oral Presentation of Additional Analyses of MM-398 Phase 3 NAPOLI-1 Study at the American Society of Clinical Oncology (ASCO) 2015 Gastrointestinal Cancers Symposium (2015/1/8)|
Click above to view more mutual fund data and stats for mack - Merrimack Pharmaceuticals Inc.